viernes, 31 de mayo de 2019

NCI at ASCO- Follow NCI's Upcoming Conference Activities


NCI at ASCO 2019


Today is the first day of the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, and we are looking forward to a great conference. 

There are many ways to engage with NCI at ASCO. Stay tuned for these daily email updates to get an overview of NCI's activities at the meeting, and visit the NCI at ASCO 2019 webpage for more information.

Visit the NCI Exhibit (#4075)

NCI Exhibit
Want to learn more about what's happening across the National Cancer Institute? Visit the NCI Exhibit from Saturday, June 1- Monday June 3 to speak with staff, learn about NCI programs and initiatives at interactive kiosks, pick up free publications, and more! 

We look forward to seeing you there.

Sessions Featuring NCI Speakers

We are pleased to share that several experts from NCI will be speaking, participating in panels and presenting posters throughout the time of conference. These sessions are highlighted below and more information can also be found in the ASCO's Annual Meeting Planner.

Naoko Takebe new

Developmental Immunotherapy and Tumor Immunobiology

Sunday, June 2, 8:00 AM - 11:00 AM
Naoko Takebe, MD, PhD, a Senior Investigator at the Investigational Drug Branch in NCI's Division of Cancer Treatment and Diagnosis will be chairing this oral abstract session that will include 14 speakers, as well as a panel Q&A session. 
Paul Pearlmen

Innovative and Affordable Global Cancer Technologies

Sunday, June 2, 4:45 PM - 6:00 PM
Join Paul Pearlman, PhD, Program Director Lead from NCI's Center for Global Health, as he chairs an education session and presents on "National Institutes of Health Efforts to Promote the Development of Affordable Innovative Cancer Technologies: Where We Are and Where We Want to Be." The session will include two other speakers, as well as a panel Q&A session. 

David Chambers

The Impact of Big Data Research on Practice, Policy, and Patient Care

Monday, June 3, 8:00 AM - 9:15 AM
David Chambers, MSc, DPhil, Deputy Director for Implementation Science in NCI's Division of Cancer Control and Population Sciences will chair this education session and present on "How to Implement and Disseminate Clinical Trial and Big Data Results." The session will include three other speakers as well as a panel Q&A session. 
Stephanie Goff

Beyond Checkpoint Blockade: An Update on Engineered T-Cell Therapy and Neoantigen Vaccine Application

Monday, June 3, 11:30 AM - 12:45 PM
Stephanie L. Goff, MD, Associate Research Physician of NCI's Center for Cancer Research will present on "Tumor Infiltrating Lymphocytes Therapy." This education session follows both the Developmental Immunotherapy and Tumor Immunobiology tracks. 
Sheila P. new

Financial Assistance for Participation in Clinical Trials: What Works Best for Patients?

Monday, June 3, 4:45 PM - 5:45 PM
Sheila Ann Prindiville, MD, MPH, Director of NCI's Coordinating Center for Clinical Trials is presenting on "NAVIGATE Program: The National Cancer Institute/Veterans Affairs Approach to Recruiting Patients to Clinical Trials." This interactive case-base session follows: Health Services Research, Clinical Informatics, and Quality of Care, Care Delivery and Practice Management, Clinical Trials, and Disparities/Health Equity tracks.

James Gulley

The Who, What, and Where of CAR T

Tuesday, June 4, 8:00 AM - 9:30 AM
This clinical science symposium will be chaired by James L. Gulley, MD, PhD, FACP, Chief of the Genitourinary Malignancies Branch in NCI's Center for Cancer Research, and will include six sessions, as well as a panel Q&A. 
Mark Roschewski

Point/Counterpoint: Duration of Therapy in Indolent Lymphoma and Chronic Lymphocytic Leukemia

Tuesday, June 4, 8:00 AM - 9:15 AM
Mark J. Roschewski, MD, Senior Clinician of the Lymphoid Malignancies Branch in NCI's Center for Cancer Research will present on "No Maintenance Required: Arguing in Favor of Observation after Frontline Therapy in Follicular Lymphoma." This education session follows both Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia tracks.

No hay comentarios:

Publicar un comentario